Massive abdominal wall hematoma and hemperitoneum secondary to subcutaneous infusion of low molecular weight heparin
García-Jiménez, A.; Alcázar Montero, J.A.; Fernández González, C.J.; Buño Ramiro, B.; Lamas García, F.D.; García de Castro, R.; Merino Rego, M.D.
Revista Espanola de Anestesiologia y Reanimacion 52(9): 572-573
2005
ISSN/ISBN: 0034-9356 PMID: 16363305 Document Number: 589741
Document emailed within 1 workday
Related Documents
Gerónimo Pardo, M.; Romero Macías, J.R.; Fuster Lluch, O. 2006: Prevention of abdominal wall hematomas in patients receiving low molecular weight heparin therapy Revista Espanola de Anestesiologia y Reanimacion 53(5): 324-5; author reply 325-6Idir, M.; Madonna, F.; Roudaut, R. 1999: Collapse and massive pulmonary edema secondary to thrombosis of a mitral mechanical heart valve prosthesis during low-molecular weight heparin therapy Journal of Heart Valve Disease 8(3): 303-304
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Mätzsch, T.; Bergqvist, D.; Blomquist, P.; Jiborn, H. 1987: Influence of standard heparin or low molecular weight heparin on healing of abdominal wounds and colonic anastomoses in rats Acta Chirurgica Scandinavica 153(10): 593-598
Sifil, A.; Mermut, C.; Yenicerioglu, Y.; Cavdar, C.; Gumustekin, M.; Celik, A.; Yuksel, F.; Camsari, T. 2003: Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 28-30
Brunkwall, J.; Mätzsch, T.; Bergqvist, D. 1990: The effect of unfractionated and low-molecular-weight heparin on the release of prostacyclin from the arterial wall Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(6): 641-645
Metz, D.; N'Guyen, P.; Chapoutot, L.; Graciet, J.; Taupin, J.M.; Grentzinger, A.; Elaerts, J.; Bajolet, A. 1991: Massive pulmonary embolism disclosing thrombocytopenia induced by low molecular weight heparin. Therapeutic success of prostacyclin Annales de Cardiologie et d'Angeiologie 40(10): 619-621
Zidane, M.; van Hulsteijn, L.H.; Brenninkmeijer, B.J.; Huisman, M.V. 2006: Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice Haematologica 91(8): 1052-1058
Kurihara, I.; Yamaguchi, Y.; Soma, J.; Sato, H.; Ito, S.; Saito, T. 2000: Two aged patients with chronic renal failure and chronic disseminated intravascular coagulation secondary to aortic aneurysms: effect of continuous subcutaneous heparin infusion therapy Nihon Jinzo Gakkai Shi 42(7): 603-607
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Bârzu, T.; Molho, P.; Tobelem, G.; Petitou, M.; Caen, J.P. 1984: Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture Nouvelle Revue Francaise d'Hematologie 26(4): 243-247
Chigot, P.; De Gennes, C.; Samama, M.M. 1996: Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin Journal des Maladies Vasculaires 21(3): 121-125